Incidence of Dementia in Elderly Latin Americans: Results of the Maracaibo Aging Study
ABSTRACT: INTRODUCTION—There are few longitudinal studies of dementia in developing countries. We used longitudinal data from the Maracaibo Aging Study (MAS) to accurately determine the age-and sex-specific incidence of dementia in elderly Latin Americans. METHODS—The DSM IV-R was used to diagnose d...
- Autores:
-
Aguirre Acevedo, Daniel Camilo
Maestre, Gladys E.
Mena, Luis J.
Melgarejo, Jesús D.
Pino Ramírez, Gloria
Urribarrí, Milady
Chacona Fonseca, Inara Josefina
Chávez, Carlos A.
Falque Madrid, Luis
Gaona, Ciro A.
Terwilliger, Joseph D.
Lee, Joseph H.
Scarmeas, Nikolaos
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2018
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/39082
- Acceso en línea:
- https://hdl.handle.net/10495/39082
- Palabra clave:
- Apolipoproteína E4
Apolipoprotein E4
Planificación en Salud Comunitaria
Community Health Planning
Evaluación Geriátrica
Geriatric Assessment
Estudios Longitudinales
Longitudinal Studies
Pruebas Neuropsicológicas
Neuropsychological Tests
Demencia
Dementia
https://id.nlm.nih.gov/mesh/D053327
https://id.nlm.nih.gov/mesh/D018672
https://id.nlm.nih.gov/mesh/D015577
https://id.nlm.nih.gov/mesh/D008137
https://id.nlm.nih.gov/mesh/D009483
https://id.nlm.nih.gov/mesh/D003704
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-nd/4.0/
| Summary: | ABSTRACT: INTRODUCTION—There are few longitudinal studies of dementia in developing countries. We used longitudinal data from the Maracaibo Aging Study (MAS) to accurately determine the age-and sex-specific incidence of dementia in elderly Latin Americans. METHODS—The DSM IV-R was used to diagnose dementia, which was classified as Alzheimer’s disease (AD), vascular dementia (VaD), or other. Age- and sex-specific incidence was estimated as the number of new cases of dementia divided by person-years of follow-up (p-y). RESULTS—The incidence of all dementia diagnoses was 9.10 per 1000 p-y (95% CI 7.13–11.44;8026 total p-y), 5.18 for AD (95% CI 3.72–7.03; 7916 total p-y), and 3.35 for VaD (95% CI 2.19–4.91;7757 total p-y). DISCUSSION—Among MAS participants under 65 years of age, the incidence of dementia was higher than that of US whites. Among individuals over 65 years of age, the incidence was comparable to the mean of previous incidence estimates for other populations worldwide. |
|---|
